Media coverage
1
Media coverage
Title US FDA approves Janssen Pharma's Carvykti to treat relapsed or refractory multiple myeloma Media name/outlet PharmaBiz Country/Territory India Date 2/03/22 Persons Sundar Jagannath
US FDA approves Janssen Pharma's Carvykti to treat relapsed or refractory multiple myeloma
Press/Media